Dissent Today, Majority Tomorrow—A Federal Circuit Approach to Rehearing
IP Watchdog
AUGUST 7, 2022
recently in Novartis Pharmaceuticals Corp. Accord Healthcare Inc. But in Novartis Pharmaceuticals v. Accord Healthcare, neither of the panel members in the majority of the original opinion even agreed to rehear the case, let alone agreed to reverse their prior ruling. Talk about snatching victory from the jaws of defeat!
Let's personalize your content